BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38388076)

  • 21. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.
    Tuttle RM; Tala H; Shah J; Leboeuf R; Ghossein R; Gonen M; Brokhin M; Omry G; Fagin JA; Shaha A
    Thyroid; 2010 Dec; 20(12):1341-9. PubMed ID: 21034228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroglobulin antibodies: Trend over time and clinical impact in differentiated thyroid carcinoma with and without radioiodine ablation.
    Iglesias ML; Calabretta JM; Coggiola O; Califano I
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Nov; 69(9):702-708. PubMed ID: 36470645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer.
    Kim HO; Lee K; Lee SM; Seo GH
    JAMA Intern Med; 2020 Jan; 180(1):54-61. PubMed ID: 31633736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer.
    Slonimsky E; Tulchinsky M
    Curr Pharm Des; 2020; 26(31):3812-3827. PubMed ID: 32503402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma.
    Özdoğan Ö; Aksu A; Doğan E; Bülbül O; Güray Durak M; Sevinç Aİ; Bayraktar F; İkiz AÖ
    Ann Nucl Med; 2021 Feb; 35(2):223-231. PubMed ID: 33389664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined BRAF
    Campennì A; Ruggeri RM; Siracusa M; Pignata SA; Di Mauro F; Vento A; Trimarchi F; Baldari S
    J Endocrinol Invest; 2018 Nov; 41(11):1283-1288. PubMed ID: 29549631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neck Ultrasound in Patients with Follicular Thyroid Carcinoma.
    Segkos K; Porter K; Senter L; Ringel MD; Nabhan FA
    Horm Cancer; 2018 Dec; 9(6):433-439. PubMed ID: 30088223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma.
    Wang J; Mao Y; Li L; Liang J; Huang H; Lin W; Chen G; Wen J
    Endocrine; 2024 May; ():. PubMed ID: 38809346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.
    Sung TY; Jeon MJ; Lee YH; Lee YM; Kwon H; Yoon JH; Chung KW; Kim WG; Song DE; Hong SJ
    J Clin Endocrinol Metab; 2017 Mar; 102(3):793-800. PubMed ID: 27809646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
    PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of delayed radioiodine therapy in intermediate-/high-risk papillary thyroid carcinoma.
    Kim M; Han M; Jeon MJ; Kim WG; Kim IJ; Ryu JS; Kim WB; Shong YK; Kim TY; Kim BH
    Clin Endocrinol (Oxf); 2019 Sep; 91(3):449-455. PubMed ID: 31102417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer Outcomes.
    Wijewardene A; Gill AJ; Gild M; Learoyd DL; Glover AR; Sywak M; Sidhu S; Roach P; Schembri G; Hoang J; Robinson B; Tacon L; Clifton-Bligh R
    Thyroid; 2022 Oct; 32(10):1201-1210. PubMed ID: 35620896
    [No Abstract]   [Full Text] [Related]  

  • 33. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
    Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
    Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature.
    Estorch M; Mitjavila M; Muros MA; Caballero E;
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):195-203. PubMed ID: 30745131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
    Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
    J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer.
    Jeong JH; Kong EJ; Jeong SY; Lee SW; Cho IH; Ah Chun K; Lee J; Ahn BC
    Nucl Med Commun; 2017 Mar; 38(3):228-233. PubMed ID: 27984538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shifting paradigms in the management of pediatric differentiated thyroid cancer from static to dynamic risk stratification: a step forward toward precision medicine.
    Ajdari SE; Shafiei B; Motazedian M; Qutbi M; Esmaeilzadeh P; Asli IN; Javadi H; Assadi M
    Nuklearmedizin; 2019 Jun; 58(3):249-257. PubMed ID: 31060081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Thyrotropin Alfa Versus Levothyroxine Withdrawal-Aided Radioiodine Therapy for Distant Metastasis of Papillary Thyroid Cancer.
    Simões-Pereira J; Ferreira TC; Limbert E; Cavaco BM; Leite V
    Thyroid; 2021 Oct; 31(10):1514-1522. PubMed ID: 34155923
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcomes after radioiodine ablation in patients with thyroid cancer: Long-term follow-up of a Chinese randomized clinicaltrial.
    Dong P; Qu Y; Yang L; Xiao L; Huang R; Li L
    Clin Endocrinol (Oxf); 2021 Nov; 95(5):782-789. PubMed ID: 34368999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.